MedCity News

Kailera’s Upsized IPO Brings In $625M for Pipeline of Injectable & Oral Obesity Drugs

Your Doctors and Nurses Are Burned Out. Here’s What They Need

These day-to-day issues are directly responsible for rising rates of clinician burnout, exacerbating the serious shortage of doctors and nurses facing the US in the next decade.

By Guillaume Castel

MedCity Influencers

Strengthening Social Security in a Changing World

The future of social security depends on the strength of our collaboration and our unwavering commitment to the people we serve. The challenges are significant, but so are the opportunities for innovation.

By Héctor Upegui

Health Tech

Wisp, Visby Partner to Expand Access to At-Home STI Test

Wisp partnered with Visby Medical to expand access to Visby’s at-home sexually transmitted infection test and provide follow-up treatment through Wisp’s telehealth platform.

By Marissa Plescia

Latest Video

Latest News

Health Tech, Startups, Providers

Omni channel technology of online retail business. Multichannel marketing on social media network platform offer service of internet payment channel, online retail shopping and omni digital app.

CMS’ New ‘App Store’ Is Trying to Turn Interoperability Into a Digital Health Distribution System

CMS is rolling out its health tech ecosystem initiative with a new Medicare app library that functions like a healthcare “App Store,” aiming to make patient data more portable and accessible across vetted digital health apps.

By Katie Adams

BioPharma, Startups

Startup Nula Emerges to Advance a New Class of Medicines for Metabolic Disease

The fatty liver disease MASH is one of the metabolic disorders that Nula Therapeutics is pursuing. The startup’s small molecules are intended to restore the integrity of the nuclear envelope, a cellular membrane whose dysfunction can contribute to metabolic disease.

By Frank Vinluan

The Power Behind Enterprise EHR Software for Large Healthcare Systems

Enterprise EHR boosts scalability, interoperability, and governance for large healthcare systems.

By Malvika Tarnekar, Director of Product Strategy, PrognoCIS by Bizmatics Inc

MedCity Influencers

The Key Biomarkers Changing How and When We Diagnose Alzheimer’s Disease

Innovations in biomarker science, particularly in cerebrospinal fluid (CSF) and blood, are expanding Alzheimer’s testing beyond specialty care.

By Maria-Magdalena Patru

MedCity Influencers

The End of Incrementalism: Why Healthcare Innovation is Finally Reshaping the Model

The difference between that last era and this one isn’t incremental. It’s categorical. Artificial intelligence isn’t optimizing the old system. It’s making the old system economically indefensible.

By Patrick Doolittle

Policy

New Bill Seeks to Lower Out-of-Pocket Drug Costs

Rep. Greg Murphy introduced a bill that would require out-of-pocket prescription drug spending to count toward patients’ deductibles and out-of-pocket maximums regardless of where the drugs are purchased.

By Marissa Plescia

The Hidden Administrative Tasks Draining Small Practices

Small practices play a critical role in healthcare delivery, but they cannot continue to absorb ever-increasing administrative demands without consequences.

By Michael Blackman, MD, MBA Chief Medical Officer, Greenway Health®

Artificial Intelligence, Health Tech

Abstract image of close-up quantum network node

Why Innovaccer Is Pouring $250M into Its Agentic AI Platform

Innovaccer is committing $250 million to expand its AI agent platform, which automates workflows across areas like prior authorization, revenue cycle management and population health. The move comes amid an ongoing debate over whether administrative AI tools can ultimately reduce costs for providers.

By Katie Adams

BioPharma, Pharma

Eli Lilly Buys Startup CrossBridge Bio to Bring a More Powerful Strike to Tumors

Eli Lilly is paying up to $300 million for CrossBridge Bio, a startup developing antibody drug conjugates that deliver two drug payloads to cancers. Beyond potentially better efficacy, CrossBio’s dual approach could also fight drug resistance.

By Frank Vinluan

MedCity Influencers

From Insight to Intervention: Why Over-the-Counter Digital Therapeutics (ODTx) are the Next Step for LLMs and Wearables

These products have yet to offer treatment solutions designed to get users from their current health state to a desired future health state. This creates a massive, untapped opening for tools that move people from awareness to action in a clinically meaningful way, without the cost and access barriers of engaging the healthcare system or requiring a prescription.

By Austin Speier and Steven Lee

MedCity Influencers

The Last Mile Problem in AI Radiology: Detection Improves, Follow-Through Breaks

The next wave of radiology AI value will come from closed-loop follow-up. An actionable finding should start a pathway with a measurable end state: the follow-up exam is completed, the referral is completed, or the recommendation is clinically resolved with a documented rationale.

By Angela Adams

Artificial Intelligence, Startups, Devices & Diagnostics, Health Tech

Digital balancing scale justice, fairness in modern technology environment. Holographic scales balance on illuminated datum background of ai circuitry. Innovation concept in abstract futuristic

Heartflow Sues Cardiac AI Rival Cleerly Over Alleged IP Theft

HeartFlow, which makes AI tools to analyze cardiac images, sued its rival Cleerly, alleging infringement on six patents. Cleerly is pushing back.

By Katie Adams

Health Tech

Vida Health Teams Up with ŌURA to Provide More Personalized Metabolic Care

Vida Health is partnering with ŌURA to use data from the Oura Ring to provide more continuous, personalized cardiometabolic care and improve patient outcomes.

By Marissa Plescia

BioPharma, Pharma

Bouncing Back From Trial Failure, Travere Wins First FDA Approval in Rare Kidney Disease

Travere Therapeutics’ Filspari is now the first FDA-approved drug for focal segmental glomerulosclerosis (FSGS), a rare kidney disease. Analysts project the pill will become a blockbuster seller.

By Frank Vinluan

5 of the Top 10 U.S. Health Systems Are Moving to This New Health IT Category. Here’s Why.

74% of healthcare AI is stuck in pilots. The reason isn't the AI, it's the data architecture underneath it. Read more to find the solution.

By Innovaccer

MedCity Influencers

Why Synthetic Data is the Antidote to Clinical Trials

To address the clinical burden and enhance R&D, companies are turning to virtual solutions. This involves synthetic data, digital twin models, and AI to speed analysis.

By Marie Hattar

MedCity Influencers

Clinical Supply Chain Hits Its AI Turning Point

The question is where will healthcare see the greatest value? Here are five use cases that define the greatest ROI for leveraging agentic AI for clinical supply chain operations.

By John Wright